FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2016/04/006848 [Registered on: 19/04/2016] Trial Registered Retrospectively
Last Modified On: 19/04/2016
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Siddha
Other (Specify) [External application]  
Study Design  Single Arm Study 
Public Title of Study   External application of Siddha medicine- Moosambara patru on Mootu veekam (Swollen Knee joint) – Short term Clinical Trial 
Scientific Title of Study   External application of Siddha medicine- Moosambara patru on Mootu veekam (Swollen Knee joint) – Short term Clinical Trial 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrAKanagarajan 
Designation  Research Officer(Siddha)  
Affiliation  SiddhaClinicalResearchUnit 
Address  SiddhaClinicalResearchUnit GovernmentSiddhaMedicalCollege campus Palayamkottai Tirunelveli District

Tirunelveli
TAMIL NADU
627002
India 
Phone  9442178440  
Fax  04622573736   
Email  crusiddha.palay@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrHMubarak 
Designation  Senior Research Fellow(Siddha) 
Affiliation  SiddhaClinicalResearchUnit 
Address  SiddhaClinicalResearchUnit GovernmentSiddha Medical Collegecampus Palayamkottai Tirunelveli District

Tirunelveli
TAMIL NADU
627002
India 
Phone  9994133214  
Fax  04622573736  
Email  mubarak.dr@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrHMubarak 
Designation  Senior Research Fellow(Siddha) 
Affiliation  SiddhaClinicalResearchUnit 
Address  SiddhaClinicalResearchUnit GovernmentSiddha Medical Collegecampus Palayamkottai Tirunelveli District

Tirunelveli
TAMIL NADU
627002
India 
Phone  9994133214  
Fax  04622573736  
Email  mubarak.dr@gmail.com  
 
Source of Monetary or Material Support  
Central Council for Research in Siddha 
 
Primary Sponsor  
Name  Central Council for Research in Siddha 
Address  Central Council for Research in Siddha, Ministry of AYUSH, Government Anna Hospital, SCRI Campus, Arumbakkam, Chennai 106  
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrAKanagarajan  Siddha Clinical Research Unit  Siddha Clinical Research Unit, Government Siddha Medical College campus, Palayamkottai, Tirunelveli 627002 Fax: 0462 2573736
Tirunelveli
TAMIL NADU 
9442178440
04622573736
crusiddha.palay@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committe of SCRU  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Swollen Knee joint,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Moosambara patru(Siddha Medicine)  Powder form drug mixed with egg white and applied over the affected knee joints 
Comparator Agent  nil  nil 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Age between 40 years to 65 years
2. Patients with knee joint swelling
(Single or Both knees)
3. Pain
4. Joint tenderness
5. Patients willing to give consent to participate in the trial
 
 
ExclusionCriteria 
Details  1. Age less than 40 years or more than 65 years
2. Patients with Diabetes mellitus/ Hepatic failure/
Renal failure,
3. Any serious underlying infectious conditions and
Hematoma
4. History of surgical interventions
5. Patients not willing to give consent to participate in the trial
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To assess the changes in the swelling of the subjects by measuring the circumference of the affected joint before and after treatment
 
To assess the changes in the swelling of the subjects by measuring the circumference of the affected joint before and after treatment
 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the safety of the trial drug while applying externally
 
To assess the safety of the trial drug while applying externally
 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   28/02/2015 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   Yet to be published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Based on the Case sheet proforma the trial subjects were recruited for the trial. At first they were sent for screening whether to confirm the diagnosis. The consent forms signed by the patients were collected and the Patient information sheet was given as per the ethical guidelines. They were asked to report to the Investigators every 5days once for a consecutive period of 15days. The recruited patients were enrolled in the register. The investigations were advised as per the protocol. The Moosambara patru25 g of medicine was given to the patients with subject I.D nos. They were asked to Applied the medicine in swollen joint for 5 days mixed with White Egg yolk as a External therapy .And every visit measuring the swollen knee joints with help of non elastic inch tap, before and after treatments. Every five days once Measurements were done consecutively for a period of 15days treatment. The data generated maintained in the excel sheet. 

 
Close